The TRAVERSE Trial was designed to evaluate the cardiovascular safety of TRT. Due to its large size and long duration, the trial offered an opportunity to study effects on prostate safety events and several efficacy endpoints.

Here you can download the TRAVERSE Study materials. This section will be updated as more information becomes available.

Please note that the hub is for internal use only. If you wish to utilise materials included in the hub externally, then the materials must be subject to local legal, medical and regulatory (LMR) review and approval.